TRAb is a third generation assay to detect anti-TSH receptor antibody using the human thyroid-stimulating monoclonal antibody M22. The M22 antibody acridinium-labelled conjugate competes with TRAb in the specimen for the bound human TSH receptor on the microparticle. Elevations of these thyrotropin receptor antibodies demonstrated high clinical sensitivity and specificity for Graves' disease when used as an aid in the differential diagnosis and etiology of hyperthyroidism. These antibodies can be classified as stimulating, inhibitory, or neutral; and the stimulating type of antibody is not subject to the typical negative feedback of elevated thyroid hormone levels. This results in continuous stimulation of the thyroid leading to the typical thyrotoxic symptoms of Graves' hyperthyroidism.
Preparation of Patient: No special preparation.